GMI Research expects Left Ventricular Assist Device in the Type segment to acquire maximum revenue share in 2017 and the forecast period, growing at a CAGR of 8.6% during 2018-2025

The Oman Ventricular Assist Device market exhibited a value of USD xx million in 2018, and is expected to reach USD xx million by 2025, growing at a CAGR of 8.1% during 2018-2025.

  • Major market growth factors are:
  • Increasing number of patients suffering from heart diseases.
  • Shortage of heart donors and increase in heart failures.
  • Rising awareness regarding Ventricular Assist Devices and their benefits.

Factors such as increasing number of patients waiting for heart transplant. Lifestyle driven cardiovascular diseases have been one of the major factors fuelling the growth in this market. In addition, rapid increase in patients suffering from cardiac diseases are expected to boost the marker growth during the forecast period.

Implantable ventricular assist devices design segment held the maximum revenue share in 2018 owing to the increasing awareness of people towards the heart disease & their treatment and decreasing rate of thrombosis. However, the transcutaneous ventricular assist devices market possesses promising growth potential and in the next few years it is expected to show signs of improvement, driven by advantages like latest technique over existing design and lowering of blood pressure.

Left ventricular assist device held the maximum revenue share in 2018 and is expected to grow at the highest rate during the forecast period because of the increase in the technological advancements in VAD devices that are being marketed in Oman and improving healthcare infrastructure.

  • Key takeaways/key essentials:
  • In 2017, Implantable design type held the maximum revenue share
  • Bridge to recovery application segment is estimated to have the highest growth rate in the forecast period due increasing number of heart donors.

Various notable players operating in Oman Ventricular Assist Device Market include Berlin Heart GmbH, ABIOMED, Inc., Astrazeneca Plc, Medtronic Plc, Arabian Medical Devices, Surgitech Equipment LLC, Samiya Group, Taiba Pharma, Al Farsi Medical Supplies and Salalah Medical Supplies Manufacturing Company.

The Oman Ventricular Assist Device market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices

The research report “Oman Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in Oman, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, Please Visit: https://www.gmiresearch.com/report/oman-ventricular-assist-device-market-by-type-left-ventricular/

Early buyers will get customization upto 25% on report

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com